New computer models predict how patients whose HIV therapy is failing will respond to any new combination of drugs, without the need for an HIV genotype: a test used in wealthy countries to read the genetic code of the virus and help select drugs to which the virus is sensitive. In fact, the models were significantly more accurate predictors of treatment response than the genotype.